Considering that overexpression of DRAK1 suppresses TRAF6-mediated NF-κB signaling, thereby attenuating cell growth and tumorigenesis of HeLa/PTX cells, we investigated whether DRAK1 alters the expression of genes involved in tumor progression. Here, STK17A is linked to neoplasm.